No Data
No Data
Tianjin Pharmaceutical Da Ren Tang Approves Sale of 13% Stake in Tianjin TSKF Pharma; Shares Surge 10%
Haleon Raising Stake in Tianjin TSKF Pharmaceutical JV to 88%
tj darentang usd (600329.SH) intends to transfer 13% equity of Tianjin SmithKline to Hercules (China) for a consideration of 1.759 billion yuan. The funds can be used for business expansion.
tj darentang usd (600329.SH) announcement, the company's affiliated joint venture company Sino-US Tianjin Skeye Pharmaceutical Co., Ltd. (referred to as "...
Express News | tj darentang usd: Intends to transfer part of the equity of the equity company.
Tianjin Pharmaceutical Da Ren Tang to Provide 832.7 Million Yuan Guarantee for Subsidiary
tj darentang usd (600329.SH): It is proposed to inject the pharmaceutical subsidiary into the controlling shareholder's subsidiary, Taiping Company, in the form of capital increase.
On September 11th, Delon (600329.SH) announced that in order to solve the issue of intra-industry competition between the listed company and the controlling shareholder, improve the company's profitability indicators, and further enhance the scale effect of the commercial sector, the company plans to transfer all the equity of its wholly-owned subsidiary, Tianjin Zhongxin Pharmaceutical Co., Ltd. (referred to as 'Pharmaceutical Company'), to its controlling shareholder, Tianjin Pharmaceutical Group Co., Ltd. (referred to as 'Pharmaceutical Group'), in the form of capital increase, and sign the 'Jinyao Dalontang Group Co., Ltd.'
No Data
No Data